Trial intelligence / Profile preview

Effect of Fibrinogen on Coagulation in Thrombocytopenia

NCT01955811Phase 4Completed

Sponsor
Medical University of Innsbruck
Start
Dec 2012
Primary completion
Aug 2014
Modality
Recombinant Proteins and Enzymes
Countries
2
01

Overview

A Phase 4 trial of Fibrinogen human in Thrombocytopenia, sponsored by Medical University of Innsbruck. Started Dec 2012; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

Thrombocytopenia

Beyond the preview

Go deeper on NCT01955811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01955811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call